SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures

Abstract Background Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing,...

Full description

Bibliographic Details
Main Authors: Ayesha Appa, Gabriel Chamie, Aenor Sawyer, Kimberly Baltzell, Kathryn Dippell, Salu Ribeiro, Elias Duarte, Joanna Vinden, CLIAHUB Consortium, Jonathan Kramer-Feldman, Shahryar Rahdari, Doug MacIntosh, Katherine Nicholson, Jonathan Im, Diane Havlir, Bryan Greenhouse
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Archives of Public Health
Subjects:
Online Access:https://doi.org/10.1186/s13690-021-00647-8
id doaj-cffaa749b4634141829817bc45aa5b73
record_format Article
spelling doaj-cffaa749b4634141829817bc45aa5b732021-07-11T11:17:24ZengBMCArchives of Public Health2049-32582021-07-017911710.1186/s13690-021-00647-8SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing proceduresAyesha Appa0Gabriel Chamie1Aenor Sawyer2Kimberly Baltzell3Kathryn Dippell4Salu Ribeiro5Elias Duarte6Joanna Vinden7CLIAHUB Consortium8Jonathan Kramer-Feldman9Shahryar Rahdari10Doug MacIntosh11Katherine Nicholson12Jonathan Im13Diane Havlir14Bryan Greenhouse15University of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineSan Francisco State UniversitySan Francisco State UniversityUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineUniversity of California, San Francisco Division of HIV, Infectious Diseases, and Global MedicineAbstract Background Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. Methods A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days (April 20th – April 23rd, 2020). Prior to testing, key preparatory elements included community mobilization, pre-registration, volunteer recruitment, and data management. On day of testing, participants were directed to a testing lane after site entry. An administrator viewed the lane-specific queue and pre-prepared test kits, linked to participants’ records. Medical personnel performed sample collection, which included finger prick with blood collection to run laboratory-based antibody testing and respiratory specimen collection for polymerase chain reaction (PCR). Results Using this 4-lane model, 1,840 participants were tested in 4 days. A median of 57 participants (IQR 47–67) were tested hourly. The fewest participants were tested on day 1 (n = 338 participants), an intentionally lower volume day, increasing to n = 571 participants on day 4. The number of testing teams was also increased to two per lane to allow simultaneous testing of multiple participants on days 2–4. Consistent staffing on all days helped optimize proficiency, and strong community partnership was essential from planning through execution. Conclusions High-volume ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was feasible when conducted in a community-led, drive-through model in a non-urban area.https://doi.org/10.1186/s13690-021-00647-8COVID-19COVID-19 diagnostic testingRural PopulationFeasability Studies
collection DOAJ
language English
format Article
sources DOAJ
author Ayesha Appa
Gabriel Chamie
Aenor Sawyer
Kimberly Baltzell
Kathryn Dippell
Salu Ribeiro
Elias Duarte
Joanna Vinden
CLIAHUB Consortium
Jonathan Kramer-Feldman
Shahryar Rahdari
Doug MacIntosh
Katherine Nicholson
Jonathan Im
Diane Havlir
Bryan Greenhouse
spellingShingle Ayesha Appa
Gabriel Chamie
Aenor Sawyer
Kimberly Baltzell
Kathryn Dippell
Salu Ribeiro
Elias Duarte
Joanna Vinden
CLIAHUB Consortium
Jonathan Kramer-Feldman
Shahryar Rahdari
Doug MacIntosh
Katherine Nicholson
Jonathan Im
Diane Havlir
Bryan Greenhouse
SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
Archives of Public Health
COVID-19
COVID-19 diagnostic testing
Rural Population
Feasability Studies
author_facet Ayesha Appa
Gabriel Chamie
Aenor Sawyer
Kimberly Baltzell
Kathryn Dippell
Salu Ribeiro
Elias Duarte
Joanna Vinden
CLIAHUB Consortium
Jonathan Kramer-Feldman
Shahryar Rahdari
Doug MacIntosh
Katherine Nicholson
Jonathan Im
Diane Havlir
Bryan Greenhouse
author_sort Ayesha Appa
title SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
title_short SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
title_full SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
title_fullStr SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
title_full_unstemmed SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
title_sort sars-cov-2 pcr and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
publisher BMC
series Archives of Public Health
issn 2049-3258
publishDate 2021-07-01
description Abstract Background Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. Methods A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days (April 20th – April 23rd, 2020). Prior to testing, key preparatory elements included community mobilization, pre-registration, volunteer recruitment, and data management. On day of testing, participants were directed to a testing lane after site entry. An administrator viewed the lane-specific queue and pre-prepared test kits, linked to participants’ records. Medical personnel performed sample collection, which included finger prick with blood collection to run laboratory-based antibody testing and respiratory specimen collection for polymerase chain reaction (PCR). Results Using this 4-lane model, 1,840 participants were tested in 4 days. A median of 57 participants (IQR 47–67) were tested hourly. The fewest participants were tested on day 1 (n = 338 participants), an intentionally lower volume day, increasing to n = 571 participants on day 4. The number of testing teams was also increased to two per lane to allow simultaneous testing of multiple participants on days 2–4. Consistent staffing on all days helped optimize proficiency, and strong community partnership was essential from planning through execution. Conclusions High-volume ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was feasible when conducted in a community-led, drive-through model in a non-urban area.
topic COVID-19
COVID-19 diagnostic testing
Rural Population
Feasability Studies
url https://doi.org/10.1186/s13690-021-00647-8
work_keys_str_mv AT ayeshaappa sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT gabrielchamie sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT aenorsawyer sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT kimberlybaltzell sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT kathryndippell sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT saluribeiro sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT eliasduarte sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT joannavinden sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT cliahubconsortium sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT jonathankramerfeldman sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT shahryarrahdari sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT dougmacintosh sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT katherinenicholson sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT jonathanim sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT dianehavlir sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
AT bryangreenhouse sarscov2pcrandantibodytestingforanentireruralcommunitymethodsandfeasibilityofhighthroughputtestingprocedures
_version_ 1721309276064972800